Bioxytran, Inc.
BIXT · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $6 | $9 | $0 | $12 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $1 | $1 | $1 | $1 |
| Enterprise Value | $7 | $11 | $1 | $14 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$0 | $0 | -$1 | -$0 |
| % Margin | – | – | – | – |
| Net Income | -$0 | $0 | -$1 | -$1 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.003 | 0 | -152.37 | -0.004 |
| % Growth | -900% | 100% | -3,809,150% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | $0 |
| Capital Expenditures | $0 | -$0 | $0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | $0 |